drugset / Trial / NCT06362226

Optimizing Ocular Outcomes: A Dual-armed Study for Periorbital Burn Management

NCT06362226

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effectiveness in using subcutaneous 5-FU/Kenalog \& topical Maxitrol Ophthalmic ointment as different therapeutic adjuncts in the prevention of pathologic remodeling after periorbital burns.

Timeline

Start
2026-06-05
Primary completion
2026-06-05
Completion
2026-06-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Maxitrol Unknown Topical
Subject Triamcinolone Other / unclassified Subcutaneous
Subject fluorouracil Small molecule Subcutaneous